NVAXNOVAVAX INC同业对比
NOVAVAX INC 与SIC 2836 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX本股 | $1.5B#8 | — | — | 1.4x#1 | 64.7%#2 | 334.8%#1 | 40.3%#1 | — | — | — | 14.4%#7 | — |
| VCEL | $2.0B#1 | 82.8x#3 | 5.5x#8 | 7.4x#3 | 16.5%#6 | 59.4%#2 | 4.0%#3 | 4.5%#2 | 4.0%#2 | 7#1 | 26.8%#6 | — |
| ADMA | $1.9B#2 | 12.3x#2 | 4.7x#7 | 3.8x#2 | 19.6%#4 | -25.7%#5 | 37.5%#2 | 36.0%#1 | 32.9%#1 | 5#2 | -43.8%#11 | — |
| COAG | $1.9B#3 | — | 4.1x#5 | — | — | — | — | 0.0%#3 | — | — | — | — |
| VIR | $1.8B#4 | — | 1.8x#1 | 25.8x#6 | -7.6%#7 | 16.1%#3 | -699.2%#5 | -44.6%#6 | — | — | 117.7%#4 | — |
| RXRX | $1.7B#5 | — | 1.9x#2 | 23.2x#5 | 26.9%#3 | -39.1%#8 | -867.9%#6 | -70.5%#8 | -175.2%#4 | — | -32.3%#10 | — |
| TSHA | $1.7B#6 | — | 4.3x#6 | 169.0x#7 | 17.3%#5 | -22.1%#4 | -1130.6%#7 | -28.1%#4 | — | — | 68.2%#5 | — |
| INBX | $1.6B#7 | — | — | 1205.0x#8 | 550.0%#1 | -108.3%#9 | -10386.5%#8 | — | — | — | 292.0%#1 | — |
| MAZE | $1.3B#9 | — | 3.0x#3 | 8.0x#4 | — | -351.0%#10 | -85.3%#4 | -28.9%#5 | -49.4%#3 | — | 4.2%#8 | — |
| CGEM | $1.3B#10 | — | 3.2x#4 | — | -100.0%#8 | -31.2%#7 | — | -53.8%#7 | — | — | 224.1%#2 | — |
| VOR | $1.3B#11 | 0.1x#1 | — | — | — | -495.3%#11 | — | — | — | — | -29.8%#9 | — |
| REPL | $1.2B#12 | — | 11.6x#9 | — | — | -26.9%#6 | — | -297.1%#9 | -7270.9%#5 | — | 130.1%#3 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-15。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议